Direct-to-consumer telehealth company advertisement that aired during the Super Bowl failed to mention side effects of the ...
The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...
Hims & Hers has shown impressive revenue growth, accelerating from 46% to 77%. Read why I downgrade HIMS stock from buy to ...
On Super Bowl Sunday, many tuning into the big game saw a controversial ad from the telehealth company Hims & Hers. The ...
11h
News Nation on MSNHims & Hers Super Bowl ad sparks weight loss drug backlashTelehealth company Hims & Hers is being called out over its Super Bowl ad going after Big Pharma and popular weight-loss ...
Telehealth company Hims & Hers stirred up controversy by debuting a 2025 Super Bowl ad touting the benefits of its ...
13h
MarketBeat on MSNGLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss TrendsThe supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to ...
This year's Super Bowl commercials relied on comic relief and highlighted noncontroversial topics, like streaming and entertainment.
By: Katie Karlson and Madeline Darby Super Bowl commercials have been a cultural phenomenon for years. However, this year, one commercial sparked widespread controversy and a heated debate about the ...
A new study suggests that using weight loss drugs such as Ozempic and Wegovy can lead to less alcohol consumption. The study, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results